Article Details
Retrieved on: 2025-01-14 20:06:00
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Eli Lilly's revenue expectations and product performance, highlighting its research and development advancements in pharmaceuticals, notably tirzepatide. It underscores Information Technology's role in operational efficiencies and potential cybersecurity risks.
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here